| 1 | GURE | GULF RESOURCES, INC. FY · 2025-12-31 | Pharmaceuticals | $6M | 0.1 |
| 2 | TRAW | Traws Pharma, Inc. TTM · 2025-09-30 | Pharmaceuticals | $6M | 0.1 |
| 3 | PMCB | PHARMACYTE BIOTECH, INC. FY · 2026-04-30 | Pharmaceuticals | $4M | 0.1 |
| 4 | NAII | NATURAL ALTERNATIVES INTERNATIONAL INC FY · 2026-06-30 | Pharmaceuticals | $8M | 0.2 |
| 5 | BON | BON NATURAL LIFE LIMITED FY · 2025-09-30 | Pharmaceuticals | $9M | 0.2 |
| 6 | AVD | AMERICAN VANGUARD CORPORATION TTM · 2026-06-30 | Other | $42M | 0.2 |
| 7 | VRAX | Virax Biolabs Group Limited FY · 2025-03-31 | Biotechnology | $1M | 0.3 |
| 8 | VHI | VALHI, INC. TTM · 2026-06-30 | Other | $405M | 0.3 |
| 9 | QCLS | Q/C Technologies, Inc. FY · 2025-12-31 | Biotechnology | $5M | 0.3 |
| 10 | TLRY | Tilray Brands, Inc. FY · 2026-05-31 | Pharmaceuticals | $497M | 0.3 |
| 11 | CRIS | CURIS, INC. FY · 2025-12-31 | Pharmaceuticals | $2M | 0.3 |
| 12 | SNDL | | Pharmaceuticals | $288M | 0.4 |
| 13 | ATYR | aTYR PHARMA INC FY · 2025-12-31 | Pharmaceuticals | $21M | 0.4 |
| 14 | LAB | Standard BioTools Inc. FY · 2025-12-31 | Pharmaceuticals | $258M | 0.5 |
| 15 | USNA | USANA HEALTH SCIENCES, INC. TTM · 2026-07-04 | Pharmaceuticals | $276M | 0.5 |
| 16 | QDEL | QUIDELORTHO CORP TTM · 2026-06-28 | Biotechnology | $909M | 0.5 |
| 17 | MOS | MOSAIC CO TTM · 2026-06-30 | Other | $6.0B | 0.5 |
| 18 | FLNA | Filana Therapeutics, Inc. FY · 2025-12-31 | Pharmaceuticals | $37M | 0.5 |
| 19 | AMRN | AMARIN CORP PLC\UK FY · 2025-12-31 | Pharmaceuticals | $244M | 0.5 |
| 20 | OGEN | ORAGENICS, INC. FY · 2025-12-31 | Pharmaceuticals | $2M | 0.6 |
| 21 | ORMP | ORAMED PHARMACEUTICALS INC. FY · 2025-12-31 | Pharmaceuticals | $178M | 0.6 |
| 22 | SCYX | SCYNEXIS, Inc. FY · 2025-12-31 | Pharmaceuticals | $40M | 0.6 |
| 23 | TENX | TENAX THERAPEUTICS, INC. FY · 2025-12-31 | Pharmaceuticals | $68M | 0.6 |
| 24 | CGC | Canopy Growth Corporation FY · 2026-03-31 | Pharmaceuticals | $320M | 0.6 |
| 25 | ACB | AURORA CANNABIS INC FY · 2025-03-31 | Pharmaceuticals | $275M | 0.6 |
| 26 | CDIO | Cardio Diagnostics Holdings, Inc. TTM · 2026-06-30 | Biotechnology | $5M | 0.7 |
| 27 | CELZ | Creative Medical Technology Holdings, Inc. TTM · 2026-06-30 | Pharmaceuticals | $6M | 0.7 |
| 28 | FMC | FMC CORPORATION TTM · 2026-06-30 | Pharmaceuticals | $1.3B | 0.8 |
| 29 | COTY | | Other | $2.6B | 0.8 |
| 30 | ERNA | Ernexa Therapeutics Inc. FY · 2024-12-31 | Pharmaceuticals | $3M | 0.8 |
| 31 | ENVB | ENVERIC BIOSCIENCES, INC. FY · 2025-12-31 | Pharmaceuticals | $7M | 0.8 |
| 32 | TOVX | THERIVA BIOLOGICS, INC. FY · 2025-12-31 | Pharmaceuticals | $10M | 0.8 |
| 33 | LTBR | LIGHTBRIDGE CORPORATION FY · 2025-12-31 | Other | $202M | 0.8 |
| 34 | TXMD | TherapeuticsMD, Inc. FY · 2025-12-31 | Pharmaceuticals | $23M | 0.9 |
| 35 | NL | NLI HOLDINGS, INC. TTM · 2026-06-30 | Other | $330M | 0.9 |
| 36 | RMTI | ROCKWELL MEDICAL, INC. FY · 2025-12-31 | Pharmaceuticals | $31M | 0.9 |
| 37 | OPK | OPKO Health, Inc. TTM · 2026-06-30 | Pharmaceuticals | $1.0B | 0.9 |
| 38 | CATX | PERSPECTIVE THERAPEUTICS, INC. FY · 2025-12-31 | Pharmaceuticals | $288M | 0.9 |
| 39 | EPC | EDGEWELL PERSONAL CARE COMPANY TTM · 2026-06-30 | Other | $1.3B | 0.9 |
| 40 | AIM | AIM IMMUNOTECH INC. FY · 2025-12-31 | Pharmaceuticals | $7M | 0.9 |
| 41 | NEUP | Neuphoria Therapeutics Inc. FY · 2025-06-30 | Pharmaceuticals | $18M | 0.9 |
| 42 | OLN | Olin Corporation TTM · 2026-06-30 | Pharmaceuticals | $1.7B | 1.0 |
| 43 | AKAN | AKANDA CORP. FY · 2024-12-31 | Pharmaceuticals | $4M | 1.0 |
| 44 | CPHI | CHINA PHARMA HOLDINGS, INC. TTM · 2026-06-30 | Pharmaceuticals | $37M | 1.0 |
| 45 | CRON | CRONOS GROUP INC. TTM · 2026-06-30 | Pharmaceuticals | $1.2B | 1.1 |
| 46 | ALTO | ALTO INGREDIENTS, INC. FY · 2025-12-31 | Other | $284M | 1.1 |
| 47 | ALB | ALBEMARLE CORPORATION TTM · 2026-06-30 | Other | $11.6B | 1.1 |
| 48 | SCL | STEPAN COMPANY FY · 2025-12-31 | Other | $1.4B | 1.1 |
| 49 | KRO | KRONOS WORLDWIDE, INC. FY · 2025-12-31 | Other | $857M | 1.1 |
| 50 | EMN | EASTMAN CHEMICAL CO TTM · 2026-06-30 | Other | $7.1B | 1.1 |
| 51 | LODE | Comstock Inc. FY · 2025-12-31 | Other | $162M | 1.2 |
| 52 | SNGX | SOLIGENIX, INC. FY · 2024-12-31 | Pharmaceuticals | $8M | 1.2 |
| 53 | SRPT | SAREPTA THERAPEUTICS, INC. FY · 2025-12-31 | Pharmaceuticals | $1.8B | 1.2 |
| 54 | DOW | | Other | $20.3B | 1.2 |
| 55 | FUL | FULLER H B CO TTM · 2026-08-29 | Other | $2.7B | 1.2 |
| 56 | MTX | MINERALS TECHNOLOGIES INC. TTM · 2026-07-05 | Other | $2.0B | 1.2 |
| 57 | AVXL | ANAVEX LIFE SCIENCES CORP. FY · 2025-09-30 | Pharmaceuticals | $140M | 1.2 |
| 58 | NEOG | Neogen Corporation FY · 2026-05-31 | Biotechnology | $2.6B | 1.3 |
| 59 | INVA | INNOVIVA, INC. FY · 2025-12-31 | Pharmaceuticals | $1.5B | 1.3 |
| 60 | DD | DUPONT DE NEMOURS, INC. TTM · 2026-06-30 | Other | $17.5B | 1.3 |
| 61 | LXU | LSB Industries, Inc. TTM · 2026-06-30 | Other | $706M | 1.3 |
| 62 | NATR | NATURE’S SUNSHINE PRODUCTS, INC. TTM · 2026-06-30 | Pharmaceuticals | $224M | 1.3 |
| 63 | MYGN | MYRIAD GENETICS, INC. TTM · 2026-06-30 | Biotechnology | $402M | 1.3 |
| 64 | SIGA | Siga Technologies INC TTM · 2026-06-30 | Pharmaceuticals | $227M | 1.4 |
| 65 | MRKR | MARKER THERAPEUTICS, INC. FY · 2025-12-31 | Pharmaceuticals | $17M | 1.4 |
| 66 | VTRS | VIATRIS INC. TTM · 2026-06-30 | Pharmaceuticals | $20.1B | 1.4 |
| 67 | LSTA | LISATA THERAPEUTICS, INC. TTM · 2026-06-30 | Pharmaceuticals | $11M | 1.4 |
| 68 | IMNN | Imunon, Inc. FY · 2025-12-31 | Pharmaceuticals | $6M | 1.4 |
| 69 | VERU | VERU INC. TTM · 2026-06-30 | Pharmaceuticals | $41M | 1.4 |
| 70 | GOVX | GEOVAX LABS, INC. FY · 2025-12-31 | Pharmaceuticals | $3M | 1.5 |
| 71 | AVNT | AVIENT CORPORATION FY · 2025-12-31 | Other | $3.6B | 1.5 |
| 72 | NKTR | Nektar Therapeutics FY · 2025-12-31 | Pharmaceuticals | $1.4B | 1.5 |
| 73 | ACNT | Ascent Industries Co. TTM · 2026-06-30 | Pharmaceuticals | $122M | 1.5 |
| 74 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 | Other | $21.7B | 1.5 |
| 75 | CRVO | CervoMed Inc. FY · 2025-12-31 | Pharmaceuticals | $38M | 1.7 |
| 76 | BMRN | BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 | Pharmaceuticals | $10.7B | 1.7 |
| 77 | CYRX | CRYOPORT, INC. TTM · 2026-06-30 | Pharmaceuticals | $853M | 1.7 |
| 78 | IOSP | INNOSPEC INC. FY · 2025-12-31 | Pharmaceuticals | $2.4B | 1.7 |
| 79 | CAPR | CAPRICOR THERAPEUTICS, INC. FY · 2025-12-31 | Pharmaceuticals | $434M | 1.8 |
| 80 | REX | REX AMERICAN RESOURCES CORPORATION TTM · 2026-07-31 | Other | $1.4B | 1.8 |
| 81 | LYB | LYONDELLBASELL INDUSTRIES N.V. TTM · 2026-06-30 | Other | $19.2B | 1.8 |
| 82 | BIIB | BIOGEN INC. TTM · 2026-03-31 | Pharmaceuticals | $33.9B | 1.8 |
| 83 | FTLF | FITLIFE BRANDS, INC. TTM · 2026-06-30 | Pharmaceuticals | $87M | 1.8 |
| 84 | PFE | PFIZER INC TTM · 2026-06-28 | Pharmaceuticals | $161.9B | 1.9 |
| 85 | FSI | FLEXIBLE SOLUTIONS INTERNATIONAL INC. TTM · 2026-06-30 | Other | $78M | 1.9 |
| 86 | CF | CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 | Other | $17.3B | 1.9 |
| 87 | MNOV | MEDICINOVA, INC. FY · 2025-12-31 | Pharmaceuticals | $76M | 2.0 |
| 88 | LXFR | LUXFER HOLDINGS PLC TTM · 2026-03-29 | Other | $466M | 2.1 |
| 89 | ABVC | ABVC BioPharma, Inc. FY · 2024-12-31 | Pharmaceuticals | $26M | 2.1 |
| 90 | RIGL | RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 | Pharmaceuticals | $912M | 2.1 |
| 91 | ROG | ROGERS CORP TTM · 2026-03-31 | Other | $2.6B | 2.2 |
| 92 | ABEO | ABEONA THERAPEUTICS INC. FY · 2025-12-31 | Pharmaceuticals | $280M | 2.2 |
| 93 | CBT | Cabot Corporation TTM · 2026-06-30 | Other | $3.8B | 2.2 |
| 94 | LFVN | LIFEVANTAGE CORP FY · 2026-06-30 | Pharmaceuticals | $75M | 2.2 |
| 95 | NTLA | INTELLIA THERAPEUTICS, INC. FY · 2025-12-31 | Biotechnology | $1.8B | 2.4 |
| 96 | REGN | REGENERON PHARMACEUTICALS, INC. TTM · 2026-06-30 | Pharmaceuticals | $78.5B | 2.5 |
| 97 | NAGE | NIAGEN BIOSCIENCE, INC. TTM · 2026-06-30 | Pharmaceuticals | $208M | 2.5 |
| 98 | ACAD | ACADIA PHARMACEUTICALS INC. TTM · 2026-06-30 | Pharmaceuticals | $3.3B | 2.6 |
| 99 | UG | UNITED-GUARDIAN, INC. TTM · 2026-06-30 | Other | $32M | 2.7 |
| 100 | ICCC | ImmuCell Corporation FY · 2025-12-31 | Biotechnology | $87M | 2.8 |